DocSym
β
Searchsearch
Search
(G21.0) Malignant neuroleptic syndrome
More details coming soon
395 290 in individuals diagnosis malignant neuroleptic syndrome confirmed
22 723 deaths with diagnosis malignant neuroleptic syndrome
6% mortality rate associated with the disease malignant neuroleptic syndrome
Diagnosis malignant neuroleptic syndrome is diagnosed Women are 1.08% more likely than Men
195 505
Men receive the diagnosis malignant neuroleptic syndrome
13 152 (6.7 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
199 785
Women receive the diagnosis malignant neuroleptic syndrome
9 571 (4.8 %)Died from this diagnosis.
Risk Group for the Disease malignant neuroleptic syndrome - Men aged 75-79 and Women aged 80-84
In Men diagnosis is most often set at age 5-9, 15-95+
Less common in men the disease occurs at Age 0-5, 10-14Less common in women the disease occurs at Age 0-14
In Women diagnosis is most often set at age 15-95+
Disease Features malignant neuroleptic syndrome
Absence or low individual and public risk
Malignant neuroleptic syndrome - what does this mean
Malignant neuroleptic syndrome is a rare but potentially life-threatening reaction to certain antipsychotic medications. it is characterized by a combination of muscle rigidity, fever, autonomic instability, altered mental status, and an elevation of the serum creatine kinase level. it is believed to be caused by an imbalance between dopamine and serotonin in the brain.
What happens during the disease - malignant neuroleptic syndrome
Malignant neuroleptic syndrome is a rare but serious neurological disorder that is caused by an adverse reaction to certain antipsychotic medications. it is thought to be caused by an imbalance in neurotransmitters, such as dopamine, that are affected by the medications. this imbalance can lead to an increase in muscle rigidity, fever, and autonomic instability. it can also cause mental confusion, delirium, and even coma in some cases.
Clinical Pattern
More details coming soon
How does a doctor diagnose
More details coming soon
Treatment and Medical Assistance
More details coming soon
28 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Malignant neuroleptic syndrome - Prevention
Malignant neuroleptic syndrome is best prevented by avoiding the use of antipsychotic medications whenever possible and by closely monitoring patients who are on them for signs of the condition. if the patient is showing signs of the condition, the medication should be discontinued immediately and the patient should be referred to a specialist for further evaluation and treatment.